pneumoconiosis market is expected to offer significant growth at a CAGR of 9.4% during the forecast period 2023-2030 | Novartis, Abbott, Eli Lilly, Sunpharma, Sanofi, Novo Nordisk, and others.

1
Contrive Datum InsightsGlobal Research And
Consulting
A complete solution to explore all the potential
aspect to drive the growth of the business
industries.
Pneumoconiosis Market
2
About Us
Contrive Datum Insights (CDI) is a market
intelligence company providing global business
information reports and services. Our exclusive
blend of quantitative forecasting and trends
analysis provides forward-looking insight for
thousands of decision makers. CDIs experienced
team of Analysts, Researchers, and Consultants
uses proprietary data sources and various tools
and techniques to gather, and analyse
information. Our business offerings represent the
latest and the most reliable information
indispensable for businesses to sustain a
competitive edge. Each CDI syndicated research
report covers a different sector such as
chemicals, materials, metals mining,
pharmaceuticals, energy, automotive, food and
beverages, semiconductors, med-devices, consumer
goods and information technology. These reports
provide in-depth analysis and deep segmentation
to possible micro levels. With wider scope and
stratified research methodology, our syndicated
reports strive to serve the overall research
requirement of clients.
3
Services O?ered

• Market Intelligence Market Opportunity
  Assessment
• Market Size Segmentation
• Market Entry Strategy
• Competitor Benchmarking
• Pricing Intelligence
• Customer Intelligence
• Sourcing Intelligence
• New-Generation Products Technologies
• Distribution Sales Channel Assessment

4
Clientele
Some of the global leading clients that we have
served
5
Clientele
Some of the global leading clients that we have
served
6
Market Overview
The pneumoconiosis market is expected to reach
USD 2,280.88 million by 2030, with a 9.40 CAGR
during the projection period.Pneumoconiosis is a
restrictive lung disease caused by breathing in
dust at work. When breathed, a number of
different things can cause pneumoconiosis. Both
living and nonliving things are to blame for this
disease. According to the Centers for Disease
Control and Prevention (CDC), 260,000 people died
of pneumoconiosis in 2013. Pneumoconiosis is
becoming more common, more people are smoking,
and air pollution is getting worse, all of which
are driving the rise of the market. About 75 of
the cases of non-asbestos pneumoconiosis reported
by the IIDB scheme in 2009 were in people over 65
years old. According to the Centers for Disease
Control and Prevention, cigarette smoking is the
top cause of death in the United States, causing
more than 480,000 deaths every year.

7
By Region
The United States has more people with
pneumoconiosis than any other country. Aside from
this, the U.S. market is growing because there
are more patients, their habits are changing, and
they are spending more on healthcare. According
to the Centers for Disease Control and
Prevention, about 15 out of every 100 people over
18 in the U.S. smoked in 2015. This means that
about 36.5 million people in the U.S. smoke at
the moment. This disease is more likely to happen
if there are more people who smoke. The market is
also growing because more people are learning
about different diagnostic methods and new
technologies.Asia-Pacific is the biggest market
for pneumoconiosis, followed by Europe. The
market will be driven by the number of smokers,
the amount of money available for study, and the
government's support for research and
development.Asia-Pacific is the fastest-growing
market region because it has a large number of
patients, a growing economy, and a lot of
possibilities.
8
The Global Pneumoconiosis Market has been
segmented into

• By Type
• Asbestosis
• Berylliosis
• Byssinosis
• Coal Workers Pneumoconiosis
• Silicosis
• Others

• Treatment Type
• Mucolytic Agent
• Antibiotic
• Others
• Route of Administration
• Oral
• Inhalation
• Others

• End Users
• Hospitals
• Homecare
• Specialty Clinics
• Others

9
The Global Pneumoconiosis Market has been
segmented into

• By Region
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe

• By Region
• North America
• US
• Canada
• Mexico
• Rest of North America
• The Middle East Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

• By Region
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific

10
Key Market Updates
Pneumoconiosis can happen when a person breathes
in dust particles such as asbestos, coal dust, or
silica. If these particles get into the lungs'
passageways or air sacs, the body will try to
fight them off by making them red and swollen.
Since there is no cure for pneumoconiosis yet,
treatment works on managing symptoms and keeping
the disease from getting worse. The treatment
plan for this disease includes oxygen therapy,
bronchodilators, antibiotics, and a mucolytic
agent. Bronchodilators are used to treat
breathing problems, while corticosteroids can
help with congestion.The rise in the number of
people who smoke around the world will be a big
factor in increasing the growth rate of the
market. In the United States, cigarette smoking
is the main cause of preventable disability,
disease, and even death, causing about 480,000
deaths each year. In the United States, nearly 13
out of every 100 people aged 18 and up (12.5
percent) have smoked cigarettes in 2020. In the
United States, this means that about 30.8 million
adults smoke. More than 16 million Americans have
a disorder linked to smoking.
11
Market Players

• Novartis
• Abbott
• Eli Lilly
• Sunpharma
• Sanofi
• Novo Nordisk
• others.

12
Customer Experiences
13

• By associating with Contrive Datum Insights (CDI)
  , customer can enjoy following benefits
• One-Stop-Destination for all research needs
  (Syndicate and Custom Reports)
• Reduced Budget and Faster Turnaround Time
• Focused Research Team - Contrive Datum Insights
  (CDI) can arrange a dedicated team of 2-3
  resources with 1 Research Manager , who will look
  after any ad-hoc needs of the client
• Dedicated Account Manager
• 24/7 availability for any custom needs of the
  client
• Flexible Partnering Model to accommodate clients
  research needs
• Access to Data-Cuts related to required Market
  for global region
• ? Industry Update on Weekly/Bi-Weekly/Monthly
  basis
• ? Market Trend Analysis on Monthly/Quarterly basis

Benefits of Association
14
Thank You!
To know more about us, please visit our website
www.contrivedatuminsights.com For sales queries
or new topics email us on anna_at_contrivedatuminsig
hts.com